Press Releases

October 13, 2023 Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution

October 5, 2023 Lupin Receives Tentative Approval from U.S. FDA for Tolvaptan Tablets

October 3, 2023 Lupin Launches Humrahi Unique Patient Support Program for Diabetes Management

September 29, 2023 Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 Manufacturing Facility

September 28, 2023 Lupin’s Joint Airways Initiative surpasses 10,000 Patients

September 22, 2023 Lupin Acquires Five Brands from Menarini

September 6, 2023 Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients

August 29, 2023 Lupin Launches Propranolol Long-Acting Capsules to Improve Heart Health in Canada

August 29, 2023 Lupin Receives Approval from U.S. FDA for Pirfenidone Capsules